Hideto Kaneshima, MD., Ph.D.

Hideto Kaneshima is the Chief Scientific Officer (CSO) at Cellsource Inc., a company specializing in regenerative medicine and biotechnology.12

Background and Education

Dr. Kaneshima has an extensive medical and scientific background:

• Born in 1952 in Niigata Prefecture, Japan1
• Graduated from Nagoya University School of Medicine in 1978, obtaining his medical license1
• Completed his doctoral program at Nagoya University Graduate School in 1983, specializing in pathology and immunology1

Career Highlights

International Experience::

• Studied at Stanford University School of Medicine in the United States from 19861
• Co-founded Systemix, a biotech venture company in Silicon Valley, serving as the director of research1
• Spent 30 years living in the United States before returning to Tokyo1

Research and Development::

• Conducted research and development in gene therapy and cell transplantation therapy1
• Published numerous research papers in international academic journals1
• Holds multiple patents in the field1

Business Experience::

• Experienced investment specialist with a demonstrated history in the biotechnology industry2
• Worked as an independent consultant in the biotechnology field, supporting venture companies and advising major corporations1

Current Role

As CSO at Cellsource Inc., Dr. Kaneshima is directly contributing to the development of new treatment methods using adipose tissue and its stem cells.1 He considers this work to be his true calling, allowing him to apply his extensive experience in biotech and healthcare to practical applications in regenerative medicine.